Mercy Hospital Fort Smith is introducing robotic-assisted bronchoscopy, offering safer early detection for lung disease.

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

A procedure that can help spot lung cancer early is now available at a hospital, saving patients long trips out of a county.

CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite a suspicious nodule during a ...

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer CyPath® Lung test supported recommendation for surveillance ...

Saliva molecular testing showed strong accuracy for pulmonary tuberculosis. Read more about this nonsputum diagnostic approach.

SAN ANTONIO - A noninvasive lung cancer diagnostic test developed by bioAffinity Technologies (NASDAQ:BIAF) helped physicians determine appropriate treatment for a 79-year-old female with a suspicious ...